[Genetic polymorphisms associated with thrombophilia and risk for developing HELLP syndrome]

Med Clin (Barc). 2013 Jan 5;140(1):42-3. doi: 10.1016/j.medcli.2012.05.007. Epub 2012 Jul 3.
[Article in Spanish]
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Activated Protein C Resistance / epidemiology
  • Activated Protein C Resistance / genetics
  • Disease Progression
  • Factor V / genetics
  • Female
  • Genetic Predisposition to Disease
  • HELLP Syndrome / epidemiology
  • HELLP Syndrome / etiology
  • HELLP Syndrome / genetics*
  • Humans
  • Hyperhomocysteinemia / epidemiology
  • Hyperhomocysteinemia / genetics
  • Lipids / blood
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Oxidative Stress / genetics
  • Plasminogen Activator Inhibitor 1 / genetics
  • Polymorphism, Genetic*
  • Polymorphism, Single Nucleotide
  • Pre-Eclampsia / blood*
  • Pregnancy
  • Pregnancy Trimester, Third
  • Promoter Regions, Genetic / genetics
  • Prothrombin / genetics
  • Risk
  • Spain / epidemiology
  • Thrombophilia / epidemiology
  • Thrombophilia / etiology
  • Thrombophilia / genetics*

Substances

  • Lipids
  • Plasminogen Activator Inhibitor 1
  • factor V Leiden
  • Factor V
  • Prothrombin
  • Methylenetetrahydrofolate Reductase (NADPH2)